Woodbridge, CT, United States of America

Ramkumar Rajamani

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 7.5

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Middletown, CT (US) (2011 - 2013)
  • Woodbridge, CT (US) (2013 - 2019)
  • Acton, MA (US) (2019 - 2020)
  • Wallingford, CT (US) (2021 - 2022)

Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Innovations of Ramkumar Rajamani: A Pioneer in HIV Research

Introduction

Ramkumar Rajamani, based in Woodbridge, CT, is an accomplished inventor with a remarkable portfolio of 19 patents. His contributions to the field of medicinal chemistry, particularly in the development of compounds for treating human immunodeficiency virus (HIV) infection, showcase his dedication to advancing pharmaceutical science.

Latest Patents

Among his latest innovations are patents for 4-oxo-3,4-dihydroquinazoline compounds that function as inhibitors of HIV replication. These compounds, including various pharmaceutically acceptable salts, are described in detail in his inventions, highlighting their potential in the treatment of HIV infection. His pioneering work emphasizes the importance of these compositions and methods in medical applications.

Career Highlights

Rajamani has made significant strides in the pharmaceutical industry, having worked with renowned companies such as Bristol-Myers Squibb Company and Syngene International Limited. His experience in these prestigious firms has equipped him with the knowledge and skills necessary to innovate in the field of drug development.

Collaborations

Throughout his career, Ramkumar has collaborated with esteemed colleagues, including Joanne J. Bronson and Carolyn Diane Dzierba. These partnerships have played a vital role in his research endeavors, contributing to the successful development of his inventions.

Conclusion

Ramkumar Rajamani's innovative work in the development of HIV treatments positions him as a key figure in the pharmaceutical landscape. His relentless pursuit of excellence in research and collaboration with leading experts continues to pave the way for advancements in medicine, ultimately benefiting patients and the scientific community alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…